SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-24-000045
Filing Date
2024-05-20
Accepted
2024-05-20 16:02:28
Documents
2
Period of Report
2024-05-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4052
2 EDGAR SUPPORTING DOCUMENT sharp_20240516poa.txt EX-24 4085
  Complete submission text file 0001735276-24-000045.txt   9874
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BIOGEN INC LEGAL DEPARTMENT 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
SHARP PHILLIP A (Reporting) CIK: 0001226295 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 24964316